General Info

Zonagen is a biopharmaceutical company that focuses on the development of new drugs to treat hormonal and reproductive system disorders. The company operates in a near-virtual manner by outsourcing the majority of tasks associated with its development programs, which include all preclinical and clinical research and development. The company also uses contract research organizations and sponsored research arrangements. Zonagen s employees oversee the work of its suppliers in regards to drug development programs for product candidates. With the assistance of clinical consultants, the company designs preclinical and clinical programs that could potentially lead to the filing of a new drug application for that indication. Proellex is the company s flagship product that is being developed to alleviate symptoms associated with both uterine fibroids and endometriosis by selectively blocking the progesterone receptor in women. Zonagen is based in The Woodlands, Texas.